Beacon Capital Management Inc (Ohio)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33K Buy
+131
New +$28.2K ﹤0.01% 76
2025
Q4
– Sell
-60
Closed -$13.9K – 139
2025
Q3
$13.9K Buy
+60
New +$12.2K ﹤0.01% 94
2022
Q4
– Sell
-50
Closed -$7K – 105
2022
Q3
$7K Buy
+50
New +$7.17K ﹤0.01% 56
2018
Q1
– Sell
-11
Closed -$1K – 76
2017
Q4
$1K Buy
+11
New +$1.04K ﹤0.01% 57
2016
Q1
– Sell
-5
Closed – – 184
2015
Q4
$0 Buy
5
+3
+150% +$173 ﹤0.01% 239
2015
Q3
$0 Buy
+2
New +$130 ﹤0.01% 234

Other funds holding ABBV

Beacon Capital Management Inc (Ohio)'s ABBV Position: Q2 2026 in Review

Beacon Capital Management Inc (Ohio) opened a new position in AbbVie (ABBV) in Q2 2026: 131 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #76 among its holdings. This is a return to the name: Beacon Capital Management Inc (Ohio) previously reported a position in ABBV as recently as Q3 2025.

Beacon Capital Management Inc (Ohio) first reported a position in ABBV in Q3 2015 and has held it in 6 quarters since. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Beacon Capital Management Inc (Ohio) held 131 shares of AbbVie worth $33K as of Q2 2026.
  • AbbVie was a new Beacon Capital Management Inc (Ohio) position in Q2 2026.
  • AbbVie made up ﹤0.01% of Beacon Capital Management Inc (Ohio)'s portfolio in Q2 2026, its #76 holding.
  • Beacon Capital Management Inc (Ohio) first reported a position in AbbVie in Q3 2015 and has held it in 6 quarters since.
  • 4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2026, filed 13 Aug 2026.